nodes	percent_of_prediction	percent_of_DWPC	metapath
Digoxin—SLCO4C1—Methotrexate—urinary bladder cancer	0.143	0.225	CbGbCtD
Digoxin—SLCO1C1—Methotrexate—urinary bladder cancer	0.1	0.158	CbGbCtD
Digoxin—ABCB1—Mitomycin—urinary bladder cancer	0.0689	0.109	CbGbCtD
Digoxin—ABCB11—Doxorubicin—urinary bladder cancer	0.0564	0.0887	CbGbCtD
Digoxin—SLCO1B3—Methotrexate—urinary bladder cancer	0.0561	0.0883	CbGbCtD
Digoxin—SLCO1A2—Methotrexate—urinary bladder cancer	0.0346	0.0545	CbGbCtD
Digoxin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0327	0.0514	CbGbCtD
Digoxin—CYP3A4—Thiotepa—urinary bladder cancer	0.0313	0.0493	CbGbCtD
Digoxin—SLC22A8—Methotrexate—urinary bladder cancer	0.0302	0.0475	CbGbCtD
Digoxin—ABCB1—Gemcitabine—urinary bladder cancer	0.0198	0.0312	CbGbCtD
Digoxin—ABCB1—Cisplatin—urinary bladder cancer	0.0144	0.0227	CbGbCtD
Digoxin—ABCB1—Etoposide—urinary bladder cancer	0.0142	0.0223	CbGbCtD
Digoxin—Cardiotoxicity—Mitomycin—urinary bladder cancer	0.0114	0.0899	CcSEcCtD
Digoxin—ABCB1—Doxorubicin—urinary bladder cancer	0.00966	0.0152	CbGbCtD
Digoxin—ABCB1—Methotrexate—urinary bladder cancer	0.00936	0.0147	CbGbCtD
Digoxin—CYP3A4—Etoposide—urinary bladder cancer	0.00849	0.0134	CbGbCtD
Digoxin—SLC51B—prostate gland—urinary bladder cancer	0.00684	0.0453	CbGeAlD
Digoxin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00579	0.00911	CbGbCtD
Digoxin—SLC51A—prostate gland—urinary bladder cancer	0.0049	0.0325	CbGeAlD
Digoxin—ATP1A4—renal system—urinary bladder cancer	0.00487	0.0322	CbGeAlD
Digoxin—Cardiotoxicity—Gemcitabine—urinary bladder cancer	0.00483	0.038	CcSEcCtD
Digoxin—Cardiotoxicity—Fluorouracil—urinary bladder cancer	0.00475	0.0374	CcSEcCtD
Digoxin—SLC22A8—urine—urinary bladder cancer	0.00456	0.0302	CbGeAlD
Digoxin—ATP1B3—prostate gland—urinary bladder cancer	0.0043	0.0284	CbGeAlD
Digoxin—Cardiotoxicity—Etoposide—urinary bladder cancer	0.00413	0.0325	CcSEcCtD
Digoxin—Electrocardiogram change—Fluorouracil—urinary bladder cancer	0.00392	0.0308	CcSEcCtD
Digoxin—ATP1A4—female reproductive system—urinary bladder cancer	0.0039	0.0258	CbGeAlD
Digoxin—ATP1B2—prostate gland—urinary bladder cancer	0.00375	0.0248	CbGeAlD
Digoxin—ATP1A2—prostate gland—urinary bladder cancer	0.00365	0.0242	CbGeAlD
Digoxin—Necrosis—Mitomycin—urinary bladder cancer	0.00343	0.027	CcSEcCtD
Digoxin—FXYD2—renal system—urinary bladder cancer	0.00322	0.0213	CbGeAlD
Digoxin—ATP1B1—prostate gland—urinary bladder cancer	0.00318	0.021	CbGeAlD
Digoxin—SLCO4C1—seminal vesicle—urinary bladder cancer	0.00317	0.021	CbGeAlD
Digoxin—ATP1B2—seminal vesicle—urinary bladder cancer	0.00317	0.021	CbGeAlD
Digoxin—ATP1A2—seminal vesicle—urinary bladder cancer	0.00309	0.0205	CbGeAlD
Digoxin—ATP1B3—renal system—urinary bladder cancer	0.00293	0.0194	CbGeAlD
Digoxin—ATP1B2—epithelium—urinary bladder cancer	0.00276	0.0182	CbGeAlD
Digoxin—ATP1B1—seminal vesicle—urinary bladder cancer	0.00269	0.0178	CbGeAlD
Digoxin—SLC51A—female reproductive system—urinary bladder cancer	0.00268	0.0177	CbGeAlD
Digoxin—SLCO4C1—renal system—urinary bladder cancer	0.00256	0.0169	CbGeAlD
Digoxin—ATP1A3—female reproductive system—urinary bladder cancer	0.00251	0.0166	CbGeAlD
Digoxin—ATP1B2—urethra—urinary bladder cancer	0.00251	0.0166	CbGeAlD
Digoxin—ATP1A2—urethra—urinary bladder cancer	0.00245	0.0162	CbGeAlD
Digoxin—SLC51A—vagina—urinary bladder cancer	0.00242	0.016	CbGeAlD
Digoxin—Electrocardiogram ST segment depression—Epirubicin—urinary bladder cancer	0.0024	0.0189	CcSEcCtD
Digoxin—SLCO4A1—prostate gland—urinary bladder cancer	0.0024	0.0159	CbGeAlD
Digoxin—ATP1B3—female reproductive system—urinary bladder cancer	0.00235	0.0155	CbGeAlD
Digoxin—ATP1B1—epithelium—urinary bladder cancer	0.00234	0.0155	CbGeAlD
Digoxin—Cardiotoxicity—Epirubicin—urinary bladder cancer	0.00231	0.0182	CcSEcCtD
Digoxin—CYP3A4—urine—urinary bladder cancer	0.00226	0.015	CbGeAlD
Digoxin—Electrocardiogram ST segment depression—Doxorubicin—urinary bladder cancer	0.00222	0.0175	CcSEcCtD
Digoxin—ATP1B1—renal system—urinary bladder cancer	0.00217	0.0143	CbGeAlD
Digoxin—Cardiotoxicity—Doxorubicin—urinary bladder cancer	0.00214	0.0168	CcSEcCtD
Digoxin—ATP1B1—urethra—urinary bladder cancer	0.00213	0.0141	CbGeAlD
Digoxin—ATP1B2—female reproductive system—urinary bladder cancer	0.00205	0.0135	CbGeAlD
Digoxin—SLCO1C1—renal system—urinary bladder cancer	0.00204	0.0135	CbGeAlD
Digoxin—SLCO4A1—seminal vesicle—urinary bladder cancer	0.00203	0.0134	CbGeAlD
Digoxin—ATP1A2—female reproductive system—urinary bladder cancer	0.00199	0.0132	CbGeAlD
Digoxin—SLCO2B1—prostate gland—urinary bladder cancer	0.00186	0.0123	CbGeAlD
Digoxin—ATP1B2—vagina—urinary bladder cancer	0.00185	0.0123	CbGeAlD
Digoxin—SLCO4C1—vagina—urinary bladder cancer	0.00185	0.0123	CbGeAlD
Digoxin—ATP1A2—vagina—urinary bladder cancer	0.0018	0.0119	CbGeAlD
Digoxin—SLCO1B3—vagina—urinary bladder cancer	0.0018	0.0119	CbGeAlD
Digoxin—ATP1B1—female reproductive system—urinary bladder cancer	0.00174	0.0115	CbGeAlD
Digoxin—ATP1A1—prostate gland—urinary bladder cancer	0.00164	0.0109	CbGeAlD
Digoxin—SLC22A8—prostate gland—urinary bladder cancer	0.00164	0.0108	CbGeAlD
Digoxin—SLCO4A1—renal system—urinary bladder cancer	0.00163	0.0108	CbGeAlD
Digoxin—SLCO4A1—urethra—urinary bladder cancer	0.0016	0.0106	CbGeAlD
Digoxin—Delirium—Thiotepa—urinary bladder cancer	0.00157	0.0124	CcSEcCtD
Digoxin—ATP1B1—vagina—urinary bladder cancer	0.00157	0.0104	CbGeAlD
Digoxin—SLC51A—lymph node—urinary bladder cancer	0.00157	0.0104	CbGeAlD
Digoxin—FXYD2—lymph node—urinary bladder cancer	0.00151	0.00997	CbGeAlD
Digoxin—SLCO1B1—renal system—urinary bladder cancer	0.00144	0.00951	CbGeAlD
Digoxin—Necrosis—Fluorouracil—urinary bladder cancer	0.00143	0.0112	CcSEcCtD
Digoxin—CYP11A1—female reproductive system—urinary bladder cancer	0.00141	0.00931	CbGeAlD
Digoxin—ATP1A1—seminal vesicle—urinary bladder cancer	0.00139	0.00919	CbGeAlD
Digoxin—ATP1B3—lymph node—urinary bladder cancer	0.00137	0.00908	CbGeAlD
Digoxin—Necrosis—Cisplatin—urinary bladder cancer	0.00135	0.0106	CcSEcCtD
Digoxin—SLCO4A1—female reproductive system—urinary bladder cancer	0.00131	0.00865	CbGeAlD
Digoxin—SLCO2B1—renal system—urinary bladder cancer	0.00127	0.00841	CbGeAlD
Digoxin—ATP1B1—Idarubicin—Valrubicin—urinary bladder cancer	0.00126	0.15	CbGdCrCtD
Digoxin—ATP1B1—Doxorubicin—Valrubicin—urinary bladder cancer	0.00126	0.15	CbGdCrCtD
Digoxin—ATP1B1—Daunorubicin—Valrubicin—urinary bladder cancer	0.00126	0.15	CbGdCrCtD
Digoxin—ATP1B1—Epirubicin—Valrubicin—urinary bladder cancer	0.00126	0.15	CbGdCrCtD
Digoxin—Necrosis—Etoposide—urinary bladder cancer	0.00124	0.00975	CcSEcCtD
Digoxin—Drug interaction—Gemcitabine—urinary bladder cancer	0.00123	0.00966	CcSEcCtD
Digoxin—ATP1A1—epithelium—urinary bladder cancer	0.00121	0.00799	CbGeAlD
Digoxin—ATP1B2—lymph node—urinary bladder cancer	0.0012	0.00793	CbGeAlD
Digoxin—SLCO4A1—vagina—urinary bladder cancer	0.00118	0.00783	CbGeAlD
Digoxin—SLCO1A2—renal system—urinary bladder cancer	0.00117	0.00774	CbGeAlD
Digoxin—ATP1A2—lymph node—urinary bladder cancer	0.00117	0.00772	CbGeAlD
Digoxin—ATP1A1—smooth muscle tissue—urinary bladder cancer	0.00116	0.0077	CbGeAlD
Digoxin—SLCO1B1—female reproductive system—urinary bladder cancer	0.00115	0.00761	CbGeAlD
Digoxin—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00115	0.00904	CcSEcCtD
Digoxin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00114	0.00897	CcSEcCtD
Digoxin—ATP1A1—renal system—urinary bladder cancer	0.00112	0.00741	CbGeAlD
Digoxin—SLC22A8—renal system—urinary bladder cancer	0.00112	0.00739	CbGeAlD
Digoxin—Vision blurred—Mitomycin—urinary bladder cancer	0.00111	0.00873	CcSEcCtD
Digoxin—Abdominal pain—Valrubicin—urinary bladder cancer	0.0011	0.00867	CcSEcCtD
Digoxin—ATP1A1—urethra—urinary bladder cancer	0.0011	0.00728	CbGeAlD
Digoxin—SLCO2B1—female reproductive system—urinary bladder cancer	0.00102	0.00673	CbGeAlD
Digoxin—Rash maculo-papular—Fluorouracil—urinary bladder cancer	0.00102	0.00801	CcSEcCtD
Digoxin—ATP1B1—lymph node—urinary bladder cancer	0.00102	0.00672	CbGeAlD
Digoxin—Asthenia—Valrubicin—urinary bladder cancer	0.001	0.00787	CcSEcCtD
Digoxin—Confusional state—Mitomycin—urinary bladder cancer	0.000968	0.00762	CcSEcCtD
Digoxin—SLCO1C1—lymph node—urinary bladder cancer	0.000954	0.00632	CbGeAlD
Digoxin—Diarrhoea—Valrubicin—urinary bladder cancer	0.000954	0.00751	CcSEcCtD
Digoxin—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00094	0.0074	CcSEcCtD
Digoxin—Cardiac arrest—Thiotepa—urinary bladder cancer	0.000934	0.00735	CcSEcCtD
Digoxin—Dizziness—Valrubicin—urinary bladder cancer	0.000922	0.00725	CcSEcCtD
Digoxin—Anorexia—Mitomycin—urinary bladder cancer	0.000915	0.0072	CcSEcCtD
Digoxin—ATP1A1—female reproductive system—urinary bladder cancer	0.000896	0.00593	CbGeAlD
Digoxin—Vomiting—Valrubicin—urinary bladder cancer	0.000886	0.00697	CcSEcCtD
Digoxin—Rash maculo-papular—Etoposide—urinary bladder cancer	0.000884	0.00695	CcSEcCtD
Digoxin—Rash—Valrubicin—urinary bladder cancer	0.000879	0.00692	CcSEcCtD
Digoxin—Dermatitis—Valrubicin—urinary bladder cancer	0.000878	0.00691	CcSEcCtD
Digoxin—Headache—Valrubicin—urinary bladder cancer	0.000873	0.00687	CcSEcCtD
Digoxin—ATP1B1—Podofilox—Etoposide—urinary bladder cancer	0.000839	0.0999	CbGdCrCtD
Digoxin—Decreased appetite—Mitomycin—urinary bladder cancer	0.000835	0.00657	CcSEcCtD
Digoxin—Nausea—Valrubicin—urinary bladder cancer	0.000828	0.00652	CcSEcCtD
Digoxin—CYP11A1—lymph node—urinary bladder cancer	0.000823	0.00545	CbGeAlD
Digoxin—ATP1A1—vagina—urinary bladder cancer	0.000811	0.00537	CbGeAlD
Digoxin—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000791	0.00623	CcSEcCtD
Digoxin—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.000773	0.00608	CcSEcCtD
Digoxin—SLCO4A1—lymph node—urinary bladder cancer	0.000765	0.00506	CbGeAlD
Digoxin—Necrosis—Methotrexate—urinary bladder cancer	0.000742	0.00584	CcSEcCtD
Digoxin—Ventricular arrhythmia—Epirubicin—urinary bladder cancer	0.000736	0.00579	CcSEcCtD
Digoxin—Necrosis—Epirubicin—urinary bladder cancer	0.000694	0.00546	CcSEcCtD
Digoxin—Asthenia—Mitomycin—urinary bladder cancer	0.000689	0.00542	CcSEcCtD
Digoxin—Ventricular arrhythmia—Doxorubicin—urinary bladder cancer	0.000681	0.00536	CcSEcCtD
Digoxin—Hallucination—Thiotepa—urinary bladder cancer	0.000676	0.00532	CcSEcCtD
Digoxin—Cardiac arrest—Etoposide—urinary bladder cancer	0.000671	0.00528	CcSEcCtD
Digoxin—Diarrhoea—Mitomycin—urinary bladder cancer	0.000657	0.00517	CcSEcCtD
Digoxin—Necrosis—Doxorubicin—urinary bladder cancer	0.000642	0.00506	CcSEcCtD
Digoxin—Dizziness—Mitomycin—urinary bladder cancer	0.000635	0.005	CcSEcCtD
Digoxin—Delirium—Epirubicin—urinary bladder cancer	0.000634	0.00499	CcSEcCtD
Digoxin—Cardiac disorder—Thiotepa—urinary bladder cancer	0.000631	0.00496	CcSEcCtD
Digoxin—Vomiting—Mitomycin—urinary bladder cancer	0.00061	0.0048	CcSEcCtD
Digoxin—Arrhythmia—Thiotepa—urinary bladder cancer	0.000607	0.00478	CcSEcCtD
Digoxin—Rash—Mitomycin—urinary bladder cancer	0.000605	0.00476	CcSEcCtD
Digoxin—Dermatitis—Mitomycin—urinary bladder cancer	0.000605	0.00476	CcSEcCtD
Digoxin—Ventricular extrasystoles—Epirubicin—urinary bladder cancer	0.000603	0.00475	CcSEcCtD
Digoxin—Headache—Mitomycin—urinary bladder cancer	0.000601	0.00473	CcSEcCtD
Digoxin—SLCO2B1—lymph node—urinary bladder cancer	0.000595	0.00394	CbGeAlD
Digoxin—Delirium—Doxorubicin—urinary bladder cancer	0.000586	0.00461	CcSEcCtD
Digoxin—ABCB1—prostate gland—urinary bladder cancer	0.000575	0.0038	CbGeAlD
Digoxin—Nausea—Mitomycin—urinary bladder cancer	0.00057	0.00449	CcSEcCtD
Digoxin—Atrioventricular block—Epirubicin—urinary bladder cancer	0.000562	0.00442	CcSEcCtD
Digoxin—Ventricular extrasystoles—Doxorubicin—urinary bladder cancer	0.000558	0.00439	CcSEcCtD
Digoxin—Vision blurred—Thiotepa—urinary bladder cancer	0.000558	0.00439	CcSEcCtD
Digoxin—CYP3A4—renal system—urinary bladder cancer	0.000553	0.00366	CbGeAlD
Digoxin—Ventricular tachycardia—Epirubicin—urinary bladder cancer	0.000545	0.00429	CcSEcCtD
Digoxin—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.000531	0.00418	CcSEcCtD
Digoxin—ATP1A1—lymph node—urinary bladder cancer	0.000524	0.00347	CbGeAlD
Digoxin—Gynaecomastia—Methotrexate—urinary bladder cancer	0.000521	0.0041	CcSEcCtD
Digoxin—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.00052	0.00409	CcSEcCtD
Digoxin—Visual impairment—Cisplatin—urinary bladder cancer	0.000514	0.00404	CcSEcCtD
Digoxin—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000511	0.00402	CcSEcCtD
Digoxin—Ventricular tachycardia—Doxorubicin—urinary bladder cancer	0.000504	0.00397	CcSEcCtD
Digoxin—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000502	0.00395	CcSEcCtD
Digoxin—Anxiety—Thiotepa—urinary bladder cancer	0.000502	0.00395	CcSEcCtD
Digoxin—Rash maculo-papular—Epirubicin—urinary bladder cancer	0.000495	0.0039	CcSEcCtD
Digoxin—Cardiac disorder—Cisplatin—urinary bladder cancer	0.000495	0.00389	CcSEcCtD
Digoxin—Confusional state—Thiotepa—urinary bladder cancer	0.000487	0.00383	CcSEcCtD
Digoxin—ABCB1—seminal vesicle—urinary bladder cancer	0.000486	0.00322	CbGeAlD
Digoxin—Arrhythmia—Cisplatin—urinary bladder cancer	0.000476	0.00375	CcSEcCtD
Digoxin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000473	0.00372	CcSEcCtD
Digoxin—Tachycardia—Thiotepa—urinary bladder cancer	0.000471	0.00371	CcSEcCtD
Digoxin—Vision blurred—Fluorouracil—urinary bladder cancer	0.000461	0.00363	CcSEcCtD
Digoxin—Anorexia—Thiotepa—urinary bladder cancer	0.00046	0.00362	CcSEcCtD
Digoxin—Rash maculo-papular—Doxorubicin—urinary bladder cancer	0.000458	0.00361	CcSEcCtD
Digoxin—Cardiac disorder—Etoposide—urinary bladder cancer	0.000453	0.00357	CcSEcCtD
Digoxin—Visual disturbance—Methotrexate—urinary bladder cancer	0.000446	0.00351	CcSEcCtD
Digoxin—CYP3A4—female reproductive system—urinary bladder cancer	0.000443	0.00293	CbGeAlD
Digoxin—ATP1B1—Daunorubicin—Epirubicin—urinary bladder cancer	0.000438	0.0521	CbGdCrCtD
Digoxin—ATP1B1—Idarubicin—Epirubicin—urinary bladder cancer	0.000438	0.0521	CbGdCrCtD
Digoxin—ATP1B1—Doxorubicin—Epirubicin—urinary bladder cancer	0.000438	0.0521	CbGdCrCtD
Digoxin—Vision blurred—Cisplatin—urinary bladder cancer	0.000437	0.00344	CcSEcCtD
Digoxin—Dyspepsia—Thiotepa—urinary bladder cancer	0.000425	0.00335	CcSEcCtD
Digoxin—ABCB1—epithelium—urinary bladder cancer	0.000422	0.00279	CbGeAlD
Digoxin—Decreased appetite—Thiotepa—urinary bladder cancer	0.00042	0.0033	CcSEcCtD
Digoxin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000417	0.00328	CcSEcCtD
Digoxin—ATP1B1—Epirubicin—Doxorubicin—urinary bladder cancer	0.000405	0.0482	CbGdCrCtD
Digoxin—ATP1B1—Idarubicin—Doxorubicin—urinary bladder cancer	0.000405	0.0482	CbGdCrCtD
Digoxin—ATP1B1—Daunorubicin—Doxorubicin—urinary bladder cancer	0.000405	0.0482	CbGdCrCtD
Digoxin—Confusional state—Fluorouracil—urinary bladder cancer	0.000403	0.00317	CcSEcCtD
Digoxin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000398	0.00313	CcSEcCtD
Digoxin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000398	0.00313	CcSEcCtD
Digoxin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000395	0.00311	CcSEcCtD
Digoxin—Anxiety—Cisplatin—urinary bladder cancer	0.000394	0.0031	CcSEcCtD
Digoxin—ABCB1—renal system—urinary bladder cancer	0.000392	0.00259	CbGeAlD
Digoxin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000391	0.00308	CcSEcCtD
Digoxin—Tachycardia—Fluorouracil—urinary bladder cancer	0.00039	0.00307	CcSEcCtD
Digoxin—Anorexia—Gemcitabine—urinary bladder cancer	0.000387	0.00305	CcSEcCtD
Digoxin—ABCB1—urethra—urinary bladder cancer	0.000385	0.00255	CbGeAlD
Digoxin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000382	0.003	CcSEcCtD
Digoxin—Anorexia—Fluorouracil—urinary bladder cancer	0.000381	0.003	CcSEcCtD
Digoxin—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000376	0.00296	CcSEcCtD
Digoxin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000371	0.00292	CcSEcCtD
Digoxin—Tachycardia—Cisplatin—urinary bladder cancer	0.000369	0.00291	CcSEcCtD
Digoxin—Anorexia—Cisplatin—urinary bladder cancer	0.000361	0.00284	CcSEcCtD
Digoxin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000353	0.00278	CcSEcCtD
Digoxin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000352	0.00277	CcSEcCtD
Digoxin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000351	0.00276	CcSEcCtD
Digoxin—Confusional state—Etoposide—urinary bladder cancer	0.00035	0.00275	CcSEcCtD
Digoxin—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000348	0.00274	CcSEcCtD
Digoxin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000347	0.00273	CcSEcCtD
Digoxin—Asthenia—Thiotepa—urinary bladder cancer	0.000346	0.00273	CcSEcCtD
Digoxin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000345	0.00271	CcSEcCtD
Digoxin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00034	0.00267	CcSEcCtD
Digoxin—Tachycardia—Etoposide—urinary bladder cancer	0.000339	0.00266	CcSEcCtD
Digoxin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000335	0.00263	CcSEcCtD
Digoxin—Anorexia—Etoposide—urinary bladder cancer	0.000331	0.0026	CcSEcCtD
Digoxin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00033	0.0026	CcSEcCtD
Digoxin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000329	0.00259	CcSEcCtD
Digoxin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000329	0.00259	CcSEcCtD
Digoxin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000327	0.00257	CcSEcCtD
Digoxin—Dizziness—Thiotepa—urinary bladder cancer	0.000319	0.00251	CcSEcCtD
Digoxin—ABCB1—female reproductive system—urinary bladder cancer	0.000314	0.00208	CbGeAlD
Digoxin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000312	0.00246	CcSEcCtD
Digoxin—Vomiting—Thiotepa—urinary bladder cancer	0.000307	0.00242	CcSEcCtD
Digoxin—Rash—Thiotepa—urinary bladder cancer	0.000304	0.0024	CcSEcCtD
Digoxin—Dermatitis—Thiotepa—urinary bladder cancer	0.000304	0.00239	CcSEcCtD
Digoxin—Headache—Thiotepa—urinary bladder cancer	0.000302	0.00238	CcSEcCtD
Digoxin—Decreased appetite—Etoposide—urinary bladder cancer	0.000302	0.00237	CcSEcCtD
Digoxin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000299	0.00236	CcSEcCtD
Digoxin—Asthenia—Gemcitabine—urinary bladder cancer	0.000291	0.00229	CcSEcCtD
Digoxin—Nausea—Thiotepa—urinary bladder cancer	0.000287	0.00226	CcSEcCtD
Digoxin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000286	0.00225	CcSEcCtD
Digoxin—ABCB1—vagina—urinary bladder cancer	0.000284	0.00188	CbGeAlD
Digoxin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000284	0.00223	CcSEcCtD
Digoxin—Visual impairment—Methotrexate—urinary bladder cancer	0.000282	0.00222	CcSEcCtD
Digoxin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000278	0.00219	CcSEcCtD
Digoxin—Abdominal pain—Etoposide—urinary bladder cancer	0.000274	0.00216	CcSEcCtD
Digoxin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000273	0.00215	CcSEcCtD
Digoxin—Asthenia—Cisplatin—urinary bladder cancer	0.000272	0.00214	CcSEcCtD
Digoxin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000271	0.00214	CcSEcCtD
Digoxin—Dizziness—Fluorouracil—urinary bladder cancer	0.000264	0.00208	CcSEcCtD
Digoxin—Visual impairment—Epirubicin—urinary bladder cancer	0.000264	0.00208	CcSEcCtD
Digoxin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000259	0.00204	CcSEcCtD
Digoxin—Vomiting—Gemcitabine—urinary bladder cancer	0.000258	0.00203	CcSEcCtD
Digoxin—Rash—Gemcitabine—urinary bladder cancer	0.000256	0.00202	CcSEcCtD
Digoxin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000256	0.00201	CcSEcCtD
Digoxin—Headache—Gemcitabine—urinary bladder cancer	0.000254	0.002	CcSEcCtD
Digoxin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000254	0.002	CcSEcCtD
Digoxin—Vomiting—Fluorouracil—urinary bladder cancer	0.000254	0.002	CcSEcCtD
Digoxin—Rash—Fluorouracil—urinary bladder cancer	0.000252	0.00198	CcSEcCtD
Digoxin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000252	0.00198	CcSEcCtD
Digoxin—Headache—Fluorouracil—urinary bladder cancer	0.00025	0.00197	CcSEcCtD
Digoxin—Asthenia—Etoposide—urinary bladder cancer	0.000249	0.00196	CcSEcCtD
Digoxin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000244	0.00192	CcSEcCtD
Digoxin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000244	0.00192	CcSEcCtD
Digoxin—Nausea—Gemcitabine—urinary bladder cancer	0.000241	0.0019	CcSEcCtD
Digoxin—Vomiting—Cisplatin—urinary bladder cancer	0.000241	0.00189	CcSEcCtD
Digoxin—Vision blurred—Methotrexate—urinary bladder cancer	0.00024	0.00189	CcSEcCtD
Digoxin—Rash—Cisplatin—urinary bladder cancer	0.000239	0.00188	CcSEcCtD
Digoxin—Dermatitis—Cisplatin—urinary bladder cancer	0.000238	0.00188	CcSEcCtD
Digoxin—Diarrhoea—Etoposide—urinary bladder cancer	0.000237	0.00187	CcSEcCtD
Digoxin—Nausea—Fluorouracil—urinary bladder cancer	0.000237	0.00187	CcSEcCtD
Digoxin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000235	0.00185	CcSEcCtD
Digoxin—Dizziness—Etoposide—urinary bladder cancer	0.000229	0.00181	CcSEcCtD
Digoxin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000226	0.00178	CcSEcCtD
Digoxin—Nausea—Cisplatin—urinary bladder cancer	0.000225	0.00177	CcSEcCtD
Digoxin—Vision blurred—Epirubicin—urinary bladder cancer	0.000225	0.00177	CcSEcCtD
Digoxin—Vomiting—Etoposide—urinary bladder cancer	0.000221	0.00174	CcSEcCtD
Digoxin—Rash—Etoposide—urinary bladder cancer	0.000219	0.00172	CcSEcCtD
Digoxin—Dermatitis—Etoposide—urinary bladder cancer	0.000218	0.00172	CcSEcCtD
Digoxin—Headache—Etoposide—urinary bladder cancer	0.000217	0.00171	CcSEcCtD
Digoxin—Palpitations—Epirubicin—urinary bladder cancer	0.000211	0.00166	CcSEcCtD
Digoxin—Confusional state—Methotrexate—urinary bladder cancer	0.000209	0.00165	CcSEcCtD
Digoxin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000208	0.00164	CcSEcCtD
Digoxin—Nausea—Etoposide—urinary bladder cancer	0.000206	0.00162	CcSEcCtD
Digoxin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000203	0.0016	CcSEcCtD
Digoxin—Anxiety—Epirubicin—urinary bladder cancer	0.000202	0.00159	CcSEcCtD
Digoxin—Anorexia—Methotrexate—urinary bladder cancer	0.000198	0.00156	CcSEcCtD
Digoxin—Confusional state—Epirubicin—urinary bladder cancer	0.000196	0.00154	CcSEcCtD
Digoxin—Palpitations—Doxorubicin—urinary bladder cancer	0.000195	0.00153	CcSEcCtD
Digoxin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00019	0.0015	CcSEcCtD
Digoxin—Tachycardia—Epirubicin—urinary bladder cancer	0.00019	0.00149	CcSEcCtD
Digoxin—Anxiety—Doxorubicin—urinary bladder cancer	0.000187	0.00147	CcSEcCtD
Digoxin—Anorexia—Epirubicin—urinary bladder cancer	0.000185	0.00146	CcSEcCtD
Digoxin—ABCB1—lymph node—urinary bladder cancer	0.000183	0.00121	CbGeAlD
Digoxin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000183	0.00144	CcSEcCtD
Digoxin—Confusional state—Doxorubicin—urinary bladder cancer	0.000181	0.00143	CcSEcCtD
Digoxin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000181	0.00142	CcSEcCtD
Digoxin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000179	0.00141	CcSEcCtD
Digoxin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000176	0.00139	CcSEcCtD
Digoxin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000176	0.00138	CcSEcCtD
Digoxin—Anorexia—Doxorubicin—urinary bladder cancer	0.000171	0.00135	CcSEcCtD
Digoxin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000171	0.00135	CcSEcCtD
Digoxin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000171	0.00135	CcSEcCtD
Digoxin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00017	0.00134	CcSEcCtD
Digoxin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000169	0.00133	CcSEcCtD
Digoxin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000168	0.00132	CcSEcCtD
Digoxin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000164	0.00129	CcSEcCtD
Digoxin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00016	0.00126	CcSEcCtD
Digoxin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000159	0.00125	CcSEcCtD
Digoxin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000158	0.00125	CcSEcCtD
Digoxin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000156	0.00123	CcSEcCtD
Digoxin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000155	0.00122	CcSEcCtD
Digoxin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000154	0.00121	CcSEcCtD
Digoxin—Asthenia—Methotrexate—urinary bladder cancer	0.000149	0.00117	CcSEcCtD
Digoxin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000148	0.00117	CcSEcCtD
Digoxin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000147	0.00116	CcSEcCtD
Digoxin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000142	0.00112	CcSEcCtD
Digoxin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000142	0.00112	CcSEcCtD
Digoxin—Asthenia—Epirubicin—urinary bladder cancer	0.000139	0.0011	CcSEcCtD
Digoxin—Dizziness—Methotrexate—urinary bladder cancer	0.000137	0.00108	CcSEcCtD
Digoxin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000133	0.00105	CcSEcCtD
Digoxin—Vomiting—Methotrexate—urinary bladder cancer	0.000132	0.00104	CcSEcCtD
Digoxin—Rash—Methotrexate—urinary bladder cancer	0.000131	0.00103	CcSEcCtD
Digoxin—Dermatitis—Methotrexate—urinary bladder cancer	0.000131	0.00103	CcSEcCtD
Digoxin—Headache—Methotrexate—urinary bladder cancer	0.00013	0.00102	CcSEcCtD
Digoxin—Asthenia—Doxorubicin—urinary bladder cancer	0.000129	0.00102	CcSEcCtD
Digoxin—Dizziness—Epirubicin—urinary bladder cancer	0.000129	0.00101	CcSEcCtD
Digoxin—Vomiting—Epirubicin—urinary bladder cancer	0.000124	0.000973	CcSEcCtD
Digoxin—Nausea—Methotrexate—urinary bladder cancer	0.000123	0.000971	CcSEcCtD
Digoxin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000123	0.000969	CcSEcCtD
Digoxin—Rash—Epirubicin—urinary bladder cancer	0.000123	0.000965	CcSEcCtD
Digoxin—Dermatitis—Epirubicin—urinary bladder cancer	0.000122	0.000964	CcSEcCtD
Digoxin—Headache—Epirubicin—urinary bladder cancer	0.000122	0.000959	CcSEcCtD
Digoxin—Dizziness—Doxorubicin—urinary bladder cancer	0.000119	0.000936	CcSEcCtD
Digoxin—Nausea—Epirubicin—urinary bladder cancer	0.000115	0.000909	CcSEcCtD
Digoxin—Vomiting—Doxorubicin—urinary bladder cancer	0.000114	0.0009	CcSEcCtD
Digoxin—Rash—Doxorubicin—urinary bladder cancer	0.000113	0.000893	CcSEcCtD
Digoxin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000113	0.000892	CcSEcCtD
Digoxin—Headache—Doxorubicin—urinary bladder cancer	0.000113	0.000887	CcSEcCtD
Digoxin—Nausea—Doxorubicin—urinary bladder cancer	0.000107	0.000841	CcSEcCtD
Digoxin—ABCB11—Metabolism—PRSS3—urinary bladder cancer	6.5e-05	0.000832	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GSTZ1—urinary bladder cancer	6.46e-05	0.000827	CbGpPWpGaD
Digoxin—SLCO1C1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.4e-05	0.00082	CbGpPWpGaD
Digoxin—ATP1A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.4e-05	0.00082	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—NAT1—urinary bladder cancer	6.12e-05	0.000784	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GSTO2—urinary bladder cancer	6.12e-05	0.000784	CbGpPWpGaD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.09e-05	0.000779	CbGpPWpGaD
Digoxin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	6.05e-05	0.000775	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.02e-05	0.000771	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—KRAS—urinary bladder cancer	6e-05	0.000769	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—KRAS—urinary bladder cancer	6e-05	0.000769	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—KRAS—urinary bladder cancer	6e-05	0.000769	CbGpPWpGaD
Digoxin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	5.97e-05	0.000764	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.94e-05	0.00076	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—TYMP—urinary bladder cancer	5.92e-05	0.000758	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	5.9e-05	0.000755	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	5.78e-05	0.00074	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.69e-05	0.000728	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—UGT2B7—urinary bladder cancer	5.6e-05	0.000717	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	5.57e-05	0.000713	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.54e-05	0.000709	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—TYMP—urinary bladder cancer	5.52e-05	0.000707	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	5.43e-05	0.000695	CbGpPWpGaD
Digoxin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	5.41e-05	0.000693	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—NAT2—urinary bladder cancer	5.35e-05	0.000685	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—TP53—urinary bladder cancer	5.34e-05	0.000683	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—TP53—urinary bladder cancer	5.34e-05	0.000683	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—TP53—urinary bladder cancer	5.34e-05	0.000683	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.3e-05	0.000679	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.21e-05	0.000667	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.2e-05	0.000666	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—TYMP—urinary bladder cancer	5.2e-05	0.000665	CbGpPWpGaD
Digoxin—ATP1B1—Hemostasis—HRAS—urinary bladder cancer	5.1e-05	0.000653	CbGpPWpGaD
Digoxin—ATP1B3—Hemostasis—HRAS—urinary bladder cancer	5.1e-05	0.000653	CbGpPWpGaD
Digoxin—ATP1B2—Hemostasis—HRAS—urinary bladder cancer	5.1e-05	0.000653	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—CYP4B1—urinary bladder cancer	5.04e-05	0.000646	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—NAT2—urinary bladder cancer	4.99e-05	0.000639	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.99e-05	0.000639	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	4.94e-05	0.000633	CbGpPWpGaD
Digoxin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	4.89e-05	0.000627	CbGpPWpGaD
Digoxin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.84e-05	0.000619	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—SLC19A1—urinary bladder cancer	4.76e-05	0.00061	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.73e-05	0.000606	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	4.72e-05	0.000605	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—NAT2—urinary bladder cancer	4.7e-05	0.000602	CbGpPWpGaD
Digoxin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.69e-05	0.000601	CbGpPWpGaD
Digoxin—SLCO2B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.64e-05	0.000594	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—PRSS3—urinary bladder cancer	4.64e-05	0.000594	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—RRM2—urinary bladder cancer	4.62e-05	0.000592	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	4.6e-05	0.000588	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	4.51e-05	0.000578	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.35e-05	0.000557	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	4.34e-05	0.000555	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—RRM2—urinary bladder cancer	4.31e-05	0.000552	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—HPGDS—urinary bladder cancer	4.28e-05	0.000548	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—ENO2—urinary bladder cancer	4.28e-05	0.000548	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.25e-05	0.000545	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.17e-05	0.000533	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—GSTT1—urinary bladder cancer	4.15e-05	0.000531	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.09e-05	0.000523	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—RRM2—urinary bladder cancer	4.06e-05	0.000519	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4e-05	0.000512	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—HPGDS—urinary bladder cancer	3.99e-05	0.000511	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—ENO2—urinary bladder cancer	3.99e-05	0.000511	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.97e-05	0.000508	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	3.92e-05	0.000502	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—GSTT1—urinary bladder cancer	3.87e-05	0.000496	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.86e-05	0.000494	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.81e-05	0.000488	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—HPGDS—urinary bladder cancer	3.76e-05	0.000481	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—ENO2—urinary bladder cancer	3.76e-05	0.000481	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.74e-05	0.000478	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.72e-05	0.000476	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	3.71e-05	0.000475	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—GSTT1—urinary bladder cancer	3.64e-05	0.000467	CbGpPWpGaD
Digoxin—SLCO1B3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.63e-05	0.000464	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.59e-05	0.000459	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.56e-05	0.000456	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.53e-05	0.000452	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.52e-05	0.00045	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.5e-05	0.000449	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—NQO1—urinary bladder cancer	3.45e-05	0.000442	CbGpPWpGaD
Digoxin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.44e-05	0.00044	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	3.39e-05	0.000434	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	3.36e-05	0.00043	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.35e-05	0.000428	CbGpPWpGaD
Digoxin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.25e-05	0.000416	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.23e-05	0.000414	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—NQO1—urinary bladder cancer	3.22e-05	0.000412	CbGpPWpGaD
Digoxin—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.21e-05	0.000411	CbGpPWpGaD
Digoxin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.21e-05	0.000411	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	3.14e-05	0.000402	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	3.14e-05	0.000402	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.12e-05	0.0004	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.12e-05	0.000399	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.07e-05	0.000393	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.07e-05	0.000392	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.07e-05	0.000392	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	3.04e-05	0.000389	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.03e-05	0.000388	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—NQO1—urinary bladder cancer	3.03e-05	0.000388	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3e-05	0.000384	CbGpPWpGaD
Digoxin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.99e-05	0.000383	CbGpPWpGaD
Digoxin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.95e-05	0.000377	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.94e-05	0.000376	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.92e-05	0.000374	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	2.9e-05	0.000371	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—GSTP1—urinary bladder cancer	2.88e-05	0.000368	CbGpPWpGaD
Digoxin—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.85e-05	0.000365	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.8e-05	0.000359	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.78e-05	0.000356	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.72e-05	0.000349	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	2.68e-05	0.000344	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	2.68e-05	0.000343	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	2.68e-05	0.000343	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—TYMS—urinary bladder cancer	2.67e-05	0.000342	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.67e-05	0.000341	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—GSTM1—urinary bladder cancer	2.64e-05	0.000338	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—NCOR1—urinary bladder cancer	2.64e-05	0.000338	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.61e-05	0.000334	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	2.6e-05	0.000333	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.6e-05	0.000332	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.57e-05	0.000329	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.56e-05	0.000328	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.56e-05	0.000328	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—GPX1—urinary bladder cancer	2.53e-05	0.000324	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	2.53e-05	0.000324	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—GSTP1—urinary bladder cancer	2.53e-05	0.000323	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.52e-05	0.000323	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.51e-05	0.000322	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	2.5e-05	0.000319	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—ERCC2—urinary bladder cancer	2.49e-05	0.000318	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	2.47e-05	0.000316	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	2.47e-05	0.000316	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.45e-05	0.000314	CbGpPWpGaD
Digoxin—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.44e-05	0.000313	CbGpPWpGaD
Digoxin—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.44e-05	0.000312	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.38e-05	0.000305	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	2.36e-05	0.000302	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—TYMS—urinary bladder cancer	2.35e-05	0.000301	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—MTHFR—urinary bladder cancer	2.34e-05	0.000299	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.32e-05	0.000297	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—GSTM1—urinary bladder cancer	2.32e-05	0.000297	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—NCOR1—urinary bladder cancer	2.32e-05	0.000297	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	2.32e-05	0.000297	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.27e-05	0.000291	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—GPX1—urinary bladder cancer	2.22e-05	0.000285	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.2e-05	0.000281	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.19e-05	0.000281	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—ERCC2—urinary bladder cancer	2.18e-05	0.000279	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	2.18e-05	0.000279	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	2.16e-05	0.000277	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.14e-05	0.000274	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.11e-05	0.00027	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.1e-05	0.000269	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.09e-05	0.000268	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—MTHFR—urinary bladder cancer	2.05e-05	0.000263	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.04e-05	0.000261	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.03e-05	0.00026	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.99e-05	0.000255	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	1.96e-05	0.000251	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	1.94e-05	0.000248	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	1.94e-05	0.000248	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—PPARG—urinary bladder cancer	1.89e-05	0.000243	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.89e-05	0.000242	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.89e-05	0.000242	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.86e-05	0.000238	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	1.86e-05	0.000238	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.83e-05	0.000234	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.82e-05	0.000233	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	1.82e-05	0.000233	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—CREBBP—urinary bladder cancer	1.82e-05	0.000233	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	1.8e-05	0.000231	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.78e-05	0.000228	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	1.77e-05	0.000226	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.74e-05	0.000223	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.73e-05	0.000221	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.71e-05	0.000219	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	1.7e-05	0.000217	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.7e-05	0.000217	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.68e-05	0.000216	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.68e-05	0.000215	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	1.68e-05	0.000215	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—PPARG—urinary bladder cancer	1.66e-05	0.000213	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.66e-05	0.000212	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.66e-05	0.000212	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—CREBBP—urinary bladder cancer	1.6e-05	0.000205	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.59e-05	0.000203	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.56e-05	0.000199	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.56e-05	0.000199	CbGpPWpGaD
Digoxin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.5e-05	0.000192	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—PTGS2—urinary bladder cancer	1.49e-05	0.000191	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.47e-05	0.000188	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.46e-05	0.000187	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.45e-05	0.000186	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.43e-05	0.000183	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	1.39e-05	0.000178	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.39e-05	0.000178	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.34e-05	0.000172	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.34e-05	0.000172	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.33e-05	0.000171	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—PTGS2—urinary bladder cancer	1.31e-05	0.000168	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.3e-05	0.000167	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—PTEN—urinary bladder cancer	1.3e-05	0.000166	CbGpPWpGaD
Digoxin—CYP11A1—Metabolism—EP300—urinary bladder cancer	1.24e-05	0.000159	CbGpPWpGaD
Digoxin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.22e-05	0.000156	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	1.21e-05	0.000155	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.19e-05	0.000152	CbGpPWpGaD
Digoxin—SLCO1B3—Metabolism—EP300—urinary bladder cancer	1.16e-05	0.000148	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.14e-05	0.000146	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—PTEN—urinary bladder cancer	1.14e-05	0.000146	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.14e-05	0.000146	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.09e-05	0.00014	CbGpPWpGaD
Digoxin—ABCB11—Metabolism—EP300—urinary bladder cancer	1.09e-05	0.000139	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.08e-05	0.000139	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.03e-05	0.000132	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	9.53e-06	0.000122	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	9.34e-06	0.00012	CbGpPWpGaD
Digoxin—SLCO1A2—Metabolism—EP300—urinary bladder cancer	9.09e-06	0.000116	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	9.03e-06	0.000116	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.93e-06	0.000114	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—TYMS—urinary bladder cancer	8.39e-06	0.000107	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	8.3e-06	0.000106	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	8.3e-06	0.000106	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8.27e-06	0.000106	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8.27e-06	0.000106	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	8.15e-06	0.000104	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	8.02e-06	0.000103	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.94e-06	0.000102	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.8e-06	9.99e-05	CbGpPWpGaD
Digoxin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	7.77e-06	9.95e-05	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	7.33e-06	9.39e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.67e-06	8.54e-05	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.95e-06	7.61e-05	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.71e-06	7.31e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.56e-06	7.12e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5.17e-06	6.62e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	5.11e-06	6.54e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	5.11e-06	6.54e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.89e-06	6.27e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.81e-06	6.15e-05	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.68e-06	5.99e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.52e-06	5.78e-05	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.08e-06	5.22e-05	CbGpPWpGaD
Digoxin—ABCB1—Metabolism—EP300—urinary bladder cancer	3.89e-06	4.98e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.66e-06	4.69e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.52e-06	4.5e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.88e-06	3.69e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.51e-06	3.22e-05	CbGpPWpGaD
Digoxin—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.4e-06	3.07e-05	CbGpPWpGaD
